Last updated: 11/07/2018 01:08:38
A randomized trial of carvedilol (a beta-adrenergic antagonist with vasodilator properties) in patients with ischemic congestive cardiomyopathy.
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A randomized trial of carvedilol (a beta-adrenergic antagonist with vasodilator properties) in patients with ischemic congestive cardiomyopathy.
Trial description: A randomized trial of carvedilol (a beta-adrenergic antagonist with vasodilator properties) in patients with ischemic congestive cardiomyopathy.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Carvedilol improves left ventricular regional wall motion in patients with heart failure of ischemic etiology. R.N. Doughty, G. Vhalley G. Gamble S. MacMahon N. Sharpe Australia-New Zealand Heart Research Collaborative Group American College of Cardiology 46th Annual Scientific Sessions 3/16/1997 Anaheim, CA; USA
Carvedilol reduces left ventricular volumes in patients with heart failure of ischemic etiology. Robert Doughty, Gillian Whalley Stephen MacMahon Norman Sharpe Australia-New Zealand Heart Failure Research Collaborative Group American College of Cardiology 45th Annual Scientific Sessions 3/24/1996 Orlando, FL; USA
Medical condition
Heart failure, Congestive
Product
carvedilol
Collaborators
Not applicable
Study date(s)
April 1992 to June 1995
Type
Not applicable
Phase
3
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1995-16-06
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website